Letter to the Editor
Sir: In his letter, Dr. Mahendran correctly observes that the recent letters from Andrade and from Saxena and Bystritsky did not discuss the issue of risperidone-induced obsessive-compulsive symptoms. However, both de novo obsessive-compulsive symptoms and exacerbations of obsessive-compulsive symptoms associated with risperidone and clozapine were reviewed in a previous report by our group3 on risperidone augmentation of SRI treatment for refractory OCD. In recent years, several more cases have added to our understanding of this phenomenon.
Save
Cite
Advertisement
GAM ID: sidebar-top